Cullinan Therapeutics Inc.
Clinical trials sponsored by Cullinan Therapeutics Inc., explained in plain language.
-
New weapon against advanced cancers enters human testing
Disease control OngoingThis is a first-in-human study to find a safe dose and see if a new drug called CLN-619 can help control advanced solid tumors. It will test CLN-619 by itself and combined with other approved cancer drugs. The study is for adults with cancers like advanced lung, cervical, or endo…
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New antibody tested for Tough-to-Treat blood cancer
Disease control OngoingThis early-stage study is testing the safety and initial effectiveness of an experimental antibody called CLN-619 in adults with multiple myeloma that has returned and stopped responding to standard treatments. The main goals are to find a safe dose and see if the treatment can s…
Phase: PHASE1 • Sponsor: Cullinan Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC